Life-long negative impacts of COVID-19 on Mother-Infant Outcomes
On March 18th, join ECFC and Einhorn Collaborative for a discussion with Columbia University researchers on the findings of the COVID-19 Mother Baby Outcomes (COMBO) Study, a research initiative launched in Spring of 2020, in response to overwhelming interest in mother-infant health during the COVID-19 pandemic.
The COMBO initiative has enrolled over 500 women who are/were pregnant during the pandemic in NYC, with the goal of understanding COVID-19 outcomes for babies and their mothers, including but not limited to: vertical transmission rates, maternal mental health, maternal olfaction, maternal cognition, changes in socioeconomic status, breastfeeding, infant health, infant neurodevelopment, infant brain development, infant risk of autism, and much more.
Most importantly, COMBO is highly focused on the mother-infant pair as a unit, recognizing that the health of one member of the pair is intrinsically related to that of the other and theorizing that this pandemic, by virtue of numerous changes in social structure including widening social inequality gaps and necessitated prolonged social distancing, is particularly likely to affect the formation of the mother-infant emotional connection, a necessary ingredient in optimal child development.
With the oldest enrolled babies now nearly a year old, COMBO is already beginning to identify numerous troubling negative health impacts in this population in areas of growth, breastfeeding rates, neurodevelopment, and mother-infant normal interactions. Given the prolonged nature of this pandemic, these effects will have devastating effects on future generations.
On this call, we’ll learn more about preliminary study findings (to be published end of February), and consider how philanthropy might respond to these findings which will affect all of the families we seek to serve.
Dr. Dani Dumitriu
Assistant Professor of Psychiatry, Department of Pediatrics
Columbia University, Irving Medical Center